https://www.aidsmap.com/news/mar-2013/simeprevir-pushes-hcv-cure-rate-above-75-hivhcv-co-infection
Adding the new hepatitis C virus (HCV) protease inhibitor simeprevir (formerly TMC435) to pegylated interferon and ribavirin cures about three-quarters of...
cure ratesimeprevirpusheshcvhiv
https://www.science20.com/news_articles/phase_ii_alloral_study_simeprevir_and_vx135_treatment_hepatitis_c-95931
Medivir AB has announced plans for a phase II proof-of-concept study of an all-oral regimen for the treatment of hepatitis C containing of Medivir/Janssen's...
phase iioralstudysimeprevirvx
https://www.aidsmap.com/news/nov-2012/simeprevir-safe-and-effective-interferonribavirin-hepatitis-c-patients-cirrhosis
The hepatitis C protease inhibitor simeprevir (formerly TMC435) was generally safe and well tolerated in people with advanced liver fibrosis or cirrhosis and...
simeprevirsafeeffectiveinterferonribavirin
https://www.news-medical.net/news/20131123/FDA-approves-OLYSIO-%28simeprevir%29-for-treatment-of-chronic-hepatitis-C-infection.aspx
Janssen Therapeutics, Division of Janssen Products, LP, announced today the U.S. Food and Drug Administration has approved OLYSIO (simeprevir), an NS3/4A...
chronic hepatitisfdaolysiosimeprevirtreatment